People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
The US Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows ...
These weight loss medications, administered via injections, work by mimicking a hormone called GLP-1, which helps regulate appetite and blood sugar levels.
The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.